{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:16:38Z","timestamp":1740179798247,"version":"3.37.3"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>In steroid-refractory acute, severe, ulcerative colitis (ASUC), salvage medical therapy with infliximab is recommended to reduce the risk of colectomy. However, the evidence supporting this practice is based on cohorts na\u00efve to biologics. Consequently, the management of patients on biologic or small molecule therapy (BST) with ASUC is not well defined.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective chart review of patients admitted with ASUC to Mount Sinai Hospital (MSH) in Toronto, Ontario from January 2018 until January 2022. Included subjects were considered to be on BST if they had received a dose of these agents within 56 days prior to admission. Our outcomes of interest included the mean difference in hospital length of stay (HLOS), rates of surgical consultation, rates of inpatient colectomies, and 90-day readmission rates between the 2 groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 185 admissions for ASUC, 76 were on BST prior to admission and 109 were not. Baseline characteristics were similar between the 2 groups. There were no significant differences in hospital length of stay (7.46 days vs 7.45 days P = .52) or in-hospital colectomy rates between the 2 groups. Patients on BST had higher rates of surgical consultation (36.8% vs 8.3% P &amp;lt; .01) and 90-day readmission rates (26.3% vs 13.8% P = .03).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We did not identify significant differences in the majority of our outcomes between the 2 groups. However, patients on BST were more likely to receive a surgical consultation during their admission and had higher rates of readmission at 90 days. Further studies evaluating the underlying factors that contribute to readmission in patients on BST in hospitals are needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jcag\/gwae017","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T21:49:58Z","timestamp":1717192198000},"page":"306-311","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of patients admitted with acute, severe ulcerative colitis on biologic therapy: a retrospective analysis from a tertiary referral hospital"],"prefix":"10.1093","volume":"7","author":[{"given":"Nasruddin","family":"Sabrie","sequence":"first","affiliation":[{"name":"University of Toronto Department of Medicine, , Toronto, ON M5S 3HS , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Jogendran","sequence":"additional","affiliation":[{"name":"Queen\u2019s University Department of Medicine, , Kingston, ON K7L 3N6 , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Jogendran","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto , Toronto, ON M5S 3HS , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4366-9076","authenticated-orcid":false,"given":"Laura E","family":"Targownik","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Mount Sinai Hospital , Toronto, ON M5S 3H2 , Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"issue":"9853","key":"2024081206505856200_CIT0001","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ord\u00e1s","year":"2012","journal-title":"Lancet."},{"issue":"5","key":"2024081206505856200_CIT0002","doi-asserted-by":"crossref","first-page":"473","DOI":"10.7861\/clinmedicine.15-5-473","article-title":"Management of acute severe ulcerative colitis (NICE CG 166)","volume":"15","author":"Macken","year":"2015","journal-title":"Clin Med (Lond)"},{"issue":"4","key":"2024081206505856200_CIT0003","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/apt.13491","article-title":"Review article: the practical management of acute severe ulcerative colitis","volume":"43","author":"Seah","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"2024081206505856200_CIT0004","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/apt.12473","article-title":"Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit","volume":"38","author":"Lynch","year":"2013","journal-title":"Aliment Pharmacol Ther."},{"issue":"11","key":"2024081206505856200_CIT0005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrgastro.2016.116","article-title":"Acute severe ulcerative colitis: from pathophysiology to clinical management","volume":"13","author":"Hindryckx","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"2024081206505856200_CIT0006","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4291\/wjgp.v5.i4.579","article-title":"Management of acute severe ulcerative colitis","volume":"5","author":"Kedia","year":"2014","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"6","key":"2024081206505856200_CIT0007","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/ecco-jcc\/jjad004","article-title":"Rescue therapies for steroid-refractory acute severe ulcerative colitis: a review","volume":"17","author":"Gisbert","year":"2023","journal-title":"J Crohns Colitis."},{"issue":"2","key":"2024081206505856200_CIT0008","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ecco-jcc\/jjab177","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment","volume":"16","author":"Spinelli","year":"2022","journal-title":"J Crohns Colitis."},{"issue":"9857","key":"2024081206505856200_CIT0009","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(12)61084-8","article-title":"Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial","volume":"380","author":"Laharie","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"2024081206505856200_CIT0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cgh.2017.06.016","article-title":"Natural history of adult ulcerative colitis in population-based cohorts: a systematic review","volume":"16","author":"Fumery","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"5","key":"2024081206505856200_CIT0011","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1155\/2015\/724359","article-title":"Characterization of inflammatory bowel disease in elderly hospitalized patients in a large central Canadian Health region","volume":"29","author":"Stepaniuk","year":"2015","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"Suppl 2","key":"2024081206505856200_CIT0012","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.5005\/jp-journals-10071-23815","article-title":"An introduction to statistics: choosing the correct statistical test","volume":"25","author":"Ranganathan","year":"2021","journal-title":"Indian J Crit Care Med"},{"issue":"2","key":"2024081206505856200_CIT0013","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cgh.2014.07.041","article-title":"An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis","volume":"13","author":"Gibson","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024081206505856200_CIT0014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/CEG.S197719","article-title":"Optimal management of acute severe ulcerative colitis (ASUC): challenges and solutions","volume":"14","author":"Holvoet","year":"2021","journal-title":"Clin Exp Gastroenterol"},{"issue":"2","key":"2024081206505856200_CIT0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.15226\/2374-8362\/1\/2\/00110","article-title":"Revisiting retrospective chart review: an evaluation of nursing home palliative and end-of-life care research","volume":"1","author":"Kaasalainen","year":"2014","journal-title":"PMCOA"},{"issue":"10","key":"2024081206505856200_CIT0016","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.dld.2008.03.014","article-title":"Colectomy rate in acute severe ulcerative colitis in the infliximab era","volume":"40","author":"Aratari","year":"2008","journal-title":"Dig Liver Dis"}],"container-title":["Journal of the Canadian Association of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcag\/article-pdf\/7\/4\/306\/58797558\/gwae017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcag\/article-pdf\/7\/4\/306\/58797558\/gwae017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T07:35:39Z","timestamp":1723448139000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcag\/article\/7\/4\/306\/7685837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5,31]]},"published-print":{"date-parts":[[2024,8,12]]}},"URL":"https:\/\/doi.org\/10.1093\/jcag\/gwae017","relation":{},"ISSN":["2515-2084","2515-2092"],"issn-type":[{"type":"print","value":"2515-2084"},{"type":"electronic","value":"2515-2092"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,5,31]]}}}